Prana Biotechnology Limited (ASX:PBT) (NASDAQ:PRAN) yesterday announced its financial results for the 12 months to June 30, 2015...
Prana Biotechnology (ASX:PBT) (NASDAQ:PRAN) has today announced the safety outcomes of the IMAGINE Extension study in patients with...
Prana Biotechnology Limited (ASX : PBT/NASDAQ : PRAN) a annoncé aujourd'hui que la Commission européenne avait approuvé la désignation...
Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) hat heute bekannt gegeben, dass die Europäische Kommission PBT2 den Status als...
Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) has today announced that the European Commission has approved orphan designation for PBT2...
http://www.fool.com.au/2015/05/22/prana-biotechnology-limited-responds-to-asx-speeding-ticket-what-you-need-to-know/
Prana Biotechnology (ASX:PBT) (NASDAQ:PRAN) is pleased to announce the European Medicines Agency’s Committee for Orphan Medicinal Products...
Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) has today announced the results of its Phase 2 trial in Huntington Disease, REACH2HD, has been...
Among the companies with shares expected to actively trade in Friday's session are Family Dollar Stores Inc. (FDO), Dollar General Corp. (DG) and...
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease PR Newswire MELBOURNE, Australia, Sept. 5, 2014 MELBOURNE, Australia...
Prana Alzheimer's disease Development Program update PR Newswire MELBOURNE, Australia, July 17, 2014 MELBOURNE, Australia, July 17, 2014...
World leader in movement disorders Professor Ira Shoulson joins Prana Board PR Newswire MELBOURNE, Australia, May 14, 2014 MELBOURNE, Australia...
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market closed higher on Monday, while quarterly performance for the main...
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market rallied on Monday, the last day of the month and quarter, as...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.